The disabled who claims for compensation must know the following points well before approaching the justice. The value of the compensation depends on

1. Age and earning capacity
2. How many asbestos containing products the plaintiff is exposed
3. The number of identifiable dependents existing
4. There are statutes of limitations to file the case from the day the disease is diagnosed. So do not delay filing

There are lawyers, lawsuit firms, insurance companies and private brokers that will assist in filing the case and for the speedy settlement. The diseased will be hard pressed for money at this juncture because he losses the job and no regular salary, medical expenses and lawyer expenses. Be careful in choosing the lawyer. the lawyer must be loyal and should understand your problem. better choose a lawyer or lawsuit firm that has dealt with mesothelioma cases and settled case record. The asbestos settlement lawsuit differ from country to country and from state to state with in the country.

New tretment and treatment techniques are now available for mesothelioma. The recent new treatment for this deadly disease is and drug is Alimta©. This drug, when combined with another long-used chemo drug called Cisplatin, is the only Food and Drug Administration approved agent designated for specific use in combating malignant pleural mesothelioma.

More details and information at our mesothelioma pages.

We are information providers on various topics for novice and experienced visitors. Our health pages offer information on common disease, killer disease and silent killers. mesothelioma and structured settlements are widely covered.

Health Info at: http://globalinfoonline.com/healthinfo.htm.

There are no posts related to Structured Settlements and Mesothelioma Cancer.

Mesothelioma is also a relatively rare form of cancer with only about 4000 cases each year. The three major varieties of mesothelioma all match up to the area of the mesothelium that is affected. They are known as Pericardial, Peritoneal and Pleural Mesothelioma.

The cancer is named after the mesothelium, which is a protective membrane that covers various cavities. Peritoneal, Pleural and Peritoneal mesothelioma are all named after the particular cavities that this cancer affects. The symptoms for each are different.

These symptoms generally show up much later on in the future after exposure to asbestos. Weight loss, abdominal pain as well as abdominal lumps are all symptoms of peritoneal mesothelioma. Pleural Mesothelioma symptoms include shortness of breath, cough (dry), lumps in the chest region, chest pain, painful breathing and coughing. Pericardial Mesothelioma symptoms are chest pains, fever, heart palpitations, difficulty breathing, murmurs, Orthopnea. It should be noted that smokers that have been exposed to asbestos have a higher than normal chance of contracting pleural mesothelioma.

In rare cases, if the cancer is caught exceedingly early, the cancer may be sent into remission. Otherwise, mesothelioma patients experience abysmal survival rates. Those suffering from advanced stages of mesothelioma usually have a year or so to live.

Those fortunate enough to uncover the cancer in its early stages can expect to live for up to 5 years. There is still research being done in the field, albeit not a whole lot. The well-known specialist, Dr.David Sugarbaker and other notable doctors elsewhere represent the few doctors that are making inroads into unraveling the mysteries of this cancer. The main areas of research tend to target pleural mesothelioma and new, aggressive techniques have been found to lengthen live expectancy by years. While a cure has still not been found for any type of cancer much less mesothelioma, there is constant research being done in the area.

Shan Durai has a website on Mesothelioma that offers free information on areas such as pleural, peritoneal and pericardial Mesothelioma as well as highlighting treatment facilities, doctors and treatment methods.

There are no posts related to Mesothelioma - What is Mesothelioma Cancer?.

The duration of exposure necessary needed for peritoneal mesothelioma to result is unknown. Abdominal pain, swelling and lumps in the abdominal as well as anemia are just a quantity of of the symptoms of this kind of cancer. Almost all patients suffering from peritoneal mesothelioma will lose their lives to it in the end.

A cure has not been found and efforts are regularly made in the region of lengthening life expectancy. The way asbestos affects the peritonium is how the cells of the membrane react to the fibers themselves. The cells begin to divide at a very high rate causing the membrane to thicken.

Fluids start to build up in the abdominal area. Treatment of peritoneal mesothelioma includes draining of the fluid in the abdomen, Cytoreductive surgery which is an attempt at removing as much discernible tumors as possible. This is then combined with chemotherapy and radiation if the situation warrants it.

The radiation and chemotherapy is used to quickly kill the dividing cells. Intraperitoneal chemotherapy is also an option where the chemicals are delivered directly into the peritonium.

The majority of patients however, are mostly too far along for radiation and chemotherapy to be effective. In such situations, the physician in charge will normally attempt to improve the quality of the patients remaining lifespan.

Indrani operates a website on Mesothelioma that offers free information on topics like peritoneal mesothelioma and mesothelioma cancer.

There are no posts related to Information On Peritoneal Mesothelioma.

When cancer affects the lung lining, it is called pleural mesothelioma. It is thought that asbestos exposure is the main cause of all kinds of mesothelioma.

Those who smoke and work around asbestos without suitable protection stand a bigger probability of getting mesothelioma. Lumps around the chest area as well as chest pains could be symptoms of pleural mesothelioma. Breathing might be impaired and even painful.

It is a difficult cancer to diagnose mostly because the symptoms resemble a lot of other conditions. Only through X-rays, CT Scans and performing a biopsy can the doctor truly discover if the patient has a confirmed case of pleural mesothelioma.

Survival rates are linked to time of discovery, the earlier, the better. In an effort to clear the affected area of tumors, the patient will commonly undergo surgery. Any tumors still left are subject to aggressive chemotherapy.

Radiation may also be used as a method of relieving the patient of the symptoms associated with pleural mesothelioma. All three methods might be used if the patient is in good health and is of a younger age.

Unfortunately, even if the cancer is in remission, the chances of it coming back is fairly high. Despite the fact that pleural mesothelioma cannot be cured, a select few such as Dr.SugarBaker are constantly striving to improve on treatments as well as testing out new techniques that hopefully are effective.

Mesothelioma and Pleural Mesothelioma are just two topics that can be found in the authors website, www.mesothelioma.my.

There are no posts related to Pleural Mesothelioma - What Is It?.

These are some steps you should take to look for the best treatment center:

1-Ask other doctors and nurses for their opinions on hospitals in your area. Your primary doctor who was the first doctor to suspect that you have this type of cancer is the first person you should ask to suggest the names of 2 -3 good mesothelioma doctors and the hospitals where they are currently practicing to you.

2-You can also seek for information from an organization called The Joint Commission. This organization accredits hospitals that meet their very stringent although not all the hospitals they accredit are expert in cancer treatment.

You can go to their website at www.jointcommision.org and do a quality check on the performance of the cancer center that you are considering. You can search for the cancer treatment center by name, zip code, or state. You can also access them by phoning 630-792-5800.

3- Another organization that will be of immense help to you is the Commission on Cancer (CoC) program of the American College of Surgeons. This program through their cancer treatment facilities approval program approves hospitals or facilities that have committed to provide the best in cancer diagnosis and treatment. Its list of approved facilities includes more than 1,400 cancer centers throughout the United States.

A good way to judge the quality of cancer care at a treatment facility is to find out if it has been approved by the CoC. If it has, you know it meets certain standards and offers a range of cancer care services. No matter its size or location, its ability to deliver quality cancer care is constantly being surveyed by the CoC.

CoC-approved cancer programs are found in many different kinds of hospitals or facilities. They may be in major treatment centers, community hospitals, or other diagnostic and treatment centers. Approved programs must provide state-of-the-art diagnostic and treatment services. They have many different specialists available to treat patients, and they can give you information on clinical trials and new treatment options. CoC-approved cancer programs also must offer life-long follow-up care to people with cancer. This gives patients ongoing long-term care so that any problems, such as late side effects, recurrences, or new cancers, are found and treated as soon as possible.
4- Finally you can also make use of the programs of the National Cancer Institute. This institute (NCI) is part of the U.S. National Institutes for Health. The NCI is dedicated to better understanding, diagnosing, treating, and preventing cancer for all people. Its goal is to support and enhance the quality of clinical cancer research. The NCI works with more than 60 cancer treatment centers in the United States. It recognizes 3 levels of cancer treatment centers, ranging from a comprehensive cancer center to the more basic cancer treatment center. These facilities are often housed at universities and research is a large focus.

You can get a list of the NCI-designated Cancer Centers and read more about the NCI by visiting the NCI Web site at www.cancer.gov. You can also learn more about your cancer and treatment options at the NCI Cancer Information Service, available at www.cancer.gov/cancertopics/factsheet/Information/CIS.
Bello kamorudeen.For more information on mesothelioma treatment go to http://www.mesotheliomacorner.blogspot.com

There are no posts related to Mesothelioma Treatment Centers- How to Find the Best One For You.

This basis is used by a German scientist named Dr. Johanna Budwig, a method that he uses is to restore the balance of essential nutrients, so as to create a balance of work of the organs. The fact that the hemoglobin content of the blood of people who suffer from cancer and other degenerative diseases are very less. But the blood of healthy people have sufficient quantities. This is also the basis of the theory that patients with cancer and degenerative diseases tend to suffer from anemia.

By combining natural and formulate a recipe that has been developed Dr.Budwig proven cancer patients after undergoing therapy flax seed oil for three months of cancer cells will be replaced with a cell body that is more alive and healthy.

The discovery of a brilliant scientist who was nominated six times the Nobel Prize has brought enlightenment to thousands of people with cancer and other degenerative diseases such as eczema, acne, psoriasis, arthritis, including in this case is mesothelioma cancer.

The success rate of treatment methods of flax seed oil has been proven by medical experts and testimonials from cancer patients from many countries. And treatment success with this method has brought a new era in cancer treatment is very promising viewed from various aspects and condition of the patient.

These expectations have exceeded the success of the treatment of cancer with conventional methods that do not just have a tendency to negatively impact large with a low success rate, but more than that we will have a greater expectation that, we can still see the people we love are still alive.

By Rofiq Hidayat

Follow me at http://www.mesothelioma-institute.blogspot.com/

There are no posts related to Alternative Cancer Treatments - Flax Seed Oil.

What Did They Know?

Asbestos is a silicate mineral used in manufacturing due to its strength and resistance to heat and fire. When inhaled, asbestos fibers can get inside the membrane that lines the lung cavity, among other tissues. This can cause cells to divide abnormally, and the result is cancer. Another complication from asbestos exposure is asbestosis, which results when the lungs have become scarred from the inhalation of asbestos, resulting in breathing difficulties. The effects of asbestos exposure can’t be reversed; symptoms can only be managed.

As early as 1937, the American Petroleum Institute wrote a document warning about the dangers of industrial dust. Most manufacturers apparently didn’t care. Even the government failed to act until 1972, when the Occupational Health and Safety Administration enacted asbestos safety rules. Meanwhile, people who worked in industries like insulation manufacturing, shipbuilding, refining, construction and mining were exposed to asbestos on a daily basis.

Most often, people who develop this type of cancer get pleural mesothelioma, in which tumors grow along the lining of the pleural cavity that holds the lungs. It’s a particularly painful disease because tumors eventually press on the lungs, kicking off the effects of pleural effusion, wherein fluid rushes to the area. Other times, people develop mesothelioma in the lining around the heart (pericardial mesothelioma) or the stomach (peritoneal mesothelioma). No matter the location, the prognosis of mesothelioma is the same: it will ultimately kill you.

Making Manufacturers Pay

In the last decade, mesothelioma patients and their families have sought to bring employers who knew about the danger to justice through legal action resulting in monetary settlements. Money will never restore a terminal cancer patient to health or bring back a lost loved one, but it helps pay bills and lost wages and sends the message that big business isn’t above the law. The good news is that many mesothelioma victims have received settlements ranging in the tens and even hundreds of millions of dollars from major corporations in steel, oil and other industries.

It’s in large part because of mesothelioma lawsuits and their related investigations that proof has come to light about companies’ knowledge of asbestos dangers. It’s been shown that, rather than correcting the problem and protecting their employees, many companies chose to look the other way in the name of profit. They are now paying for that negligence to the tune of millions of dollars.

If you or a loved one has been diagnosed with mesothelioma cancer, it is a good idea to consult a personal injury lawyer, such as a Seattle, New Jersey or Pensacola personal injury lawyer, regarding the possibility of financial compensation.

There are no posts related to Holding Manufacturers Financially Liable for Mesothelioma.

There were three postoperative complications (16%) requiring reoperation and one postoperative death (5%). Intrapleural chemotherapy was well tolerated with no complications. Systemic chemotherapy was poorly tolerated, and there was one chemotherapy-related death. Sixteen patients (84%) experienced good to excellent palliation. Three patients are currently alive with no evidence of recurrent disease at 10, 35, and 43 months. The median overall survival was 13 months and the median disease-free survival, 11 months. Overall and disease-free 3 year survivals were 17% and 22%, respectively. Patients with epithelial malignant pleural mesothelioma had significantly better overall survival (p = 0.037) and disease-free survival (p = 0.02) than patients with sarcomatous or biphasic malignant pleural mesothelioma.

Another study is called, “Cisplatin administered by the intracavitary route as treatment for malignant mesothelioma” by Maurie Markman MD, Stephen Cleary PA-C, Craig Pfeifle MD, Stephen B. Howell MD, Cancer Volume 58, Issue 1, pages 18–21, 1 July 1986. Here is an excerpt: “Abstract – Twenty-one patients with malignant mesothelioma were treated with an experimental Intracavitary chemotherapy regimen of weekly intraperitoneal or intrapleural cisplatin (90–100 mg/m2) with simultaneous intravenous sodium thiosulfate delivered to protect against cisplatin-induced nephrotoxicity. One of eight patients (12.5%) receiving intrapleural therapy and nine of 13 patients receiving intraperitoneal therapy demonstrated objective evidence of a clinical response, including three surgically defined major tumor regressions (23%). Patients receiving intrapleural treatment had more advanced disease prior to therapy than those receiving intraperitoneal therapy. It was concluded that intraperitoneal cisplatin is an active treatment program for intra-abdominally localized mesothelioma. Additional investigation of intrapleural cisplatin should be undertaken in a patient population with less advanced disease or following surgical debulking.” Cancer 58:18–21, 1986.

We all owe a debt of gratitude to these fine researchers. If you found any of these excerpts interesting, please read the studies in their entirety.
Montwrobleski77

Monty Wrobleski is the author of this article. For more information please click on the following links

Depuy Hip Recall Attorney

Depuy Hip Recall Attorney

Malignant Mesothelioma

There are no posts related to Unresectable Pleural and Peritoneal Mesothelioma Research.

Another interesting study is called, “Cytologic differential diagnosis among reactive mesothelial cells, malignant mesothelioma, and adenocarcinoma – Utility of combined E-cadherin and calretinin immunostaining” by Hiromi Kitazume C.T., Kazuhisa Kitamura C.T. Katsuhiko Mukai M.D., Yoshiaki Inayama M.D., Naomi Kawano M.D., Nobuo Nakamura M.D., Jinyu Sano M.D., Kunihiro Mitsui C.T., Sachiko Yoshida M.D., Yukio Nakatani M.D. – Cancer Cytopathology – Volume 90, Issue 1, pages 55–60, 25 February 2000. Here is an excerpt: “The differential diagnosis between reactive mesothelial cells (RMs), malignant mesotheliomas (MMs), and adenocarcinomas (ACs) is often difficult in cytologic specimens, and the utility of various immunohistochemical markers have been explored. Because recent immunohistologic studies have suggested that E-cadherin (E-cad) and calretinin (Cal) may be useful markers for epithelial and mesothelial differentiations, respectively, the authors investigated their utility in cytologic diagnosis. METHODS – In this retrospective study, immunostaining was performed on smears retrieved from Papanicolaou-stained slides of effusions using the labeled streptavidin-biotin method. Sixteen cases of RM, 9 cases of MM, and 52 cases of AC from various sites, including 13 pulmonary primaries, were examined with primary antibodies against E-cad and Cal – RESULTS The positive rates for E-cad and Cal, respectively, were as follows: RM, 0/16 (0%) and 16/16 (100%); MM, 9/9 (100%) and 8/8 (100%); and AC, 45/52 (86.5%) and 0/51 (0%). The E-cad expression by neoplastic cells was strongest in the intercellular junctions, and poorly differentiated neoplastic cells in the single cell form showed the weakest expression. CONCLUSIONS – In contrast to the results of previous immunohistochemical studies, the current study indicates that MMs constantly express E-cad, whereas RMs lack its expression in cytologic specimens, which would be useful in the differential diagnosis between the two. On the other hand, E-cad expression is not reliable for distinguishing AC from MM. The Cal expression can be a very useful marker for the distinction between AC and the mesothelial lineage. The combined immunostaining for E-cad and Cal has utility in differential diagnosis among RM, MM, and AC. Cancer (Cancer Cytopathol) 2000;90:55–60. © 2000 American Cancer Society.

It has long been a major diagnostic challenge to distinguish among reactive mesothelial cells (RMs), malignant mesothelioma (MM), and adenocarcinoma (AC) in both cytologic and surgical pathologic specimens. For differential diagnosis between MM and AC, previous immunohistochemical and immunocytochemical studies established panels of useful antibodies against immunodeterminants, including carcinoembryonic antigen (CEA), CD15 (recognized by the monoclonal antibody Leu M1), tumor-associated glycoprotein 72 (recognized by the monoclonal antibody B72.3), BerEP4 glycoprotein, and MOC-31 glycoprotein.1–5 Most of these are markers for AC and can be useful in the setting of differential diagnosis between RM and AC as well. For differentiation between RMs and MMs, on the other hand, only a few markers have been reported to be of utility. Among these are epithelial membrane antigen (EMA) and p53 protein, which are often expressed in MMs but usually not in RMs.6, 7 Recently, two new immunohistochemical markers have come into notice: E-cadherin for ACs8, 9 and calretinin for the mesothelial lineage.10 Because there are only a few reports of experience with the immuonostaining of these new markers in cytologic specimens,11, 12 we investigated their utility in cytologic differential diagnosis.”

We all owe a debt of gratitude to these fine researchers. If you found any of these excerpts interesting, please read the studies in their entirety.
Montwrobleski77

Monty Wrobleski is the author of this article. For more information please click on the following links

Depuy Hip Recall Lawyer

Depuy Hip Recall Lawyer

Malignant Mesothelioma

There are no posts related to Pleurectomy and Decortication Followed by Immediate Intrapleural Chemotherapy.

Another interesting study is called, “Successful adenovirus-mediated gene transfer in an in vivo model of human malignant Mesothelioma” – The Annals of Thoracic Surgery Volume 57, Issue 6, June 1994, Pages 1395-1401 – by W.Roy Smythe MDa, Larry R. Kaiser MD, Harry C. Hwang BS, Kunjlata M. Amin PhD, Joseph M. Pilewski MD, Stephen J. Eck MD, PhD, James M. Wilson MD, PhD and Steven M. Albelda MD – Here is an excerpt: “Abstract – Malignant mesothelioma remains a frustrating clinical problem with uniformly poor responses to current therapeutic regimens. However, the localized nature of the disease, the potential accessibility of the tumor, and the relative lack of distant metastases make it a particularly attractive candidate for somatic gene therapy. The purpose of this study was to evaluate the ability of an adenoviral vector system to transfer genetic material to human mesothelioma cells in vitro and in vivo. Using a replication-deficient recombinant adenovirus carrying the Escherichia coli lacZ market gene, we found that human mesothelioma cell lines were susceptible to adenovirus infection. Furthermore, surprisingly effective gene transfer was accomplished within tumor implants of human mesothelioma growing within the peritoneal cavity c. immunodeficient mice after intraperitoneal administration of virus. These studies demonstrate that adenoviral vectors hold promise as vehicles to deliver gene therapy in human malignant mesothelioma.”

Another interesting study is called, “Immunohistochemical staining for vimentin and keratin in malignant Mesothelioma” by Churg, Andrew M.D; From the Department of Pathology, University of British Columbia, Vancouver, British Columbia, Canada.  May 1985 – Volume 9 – Issue 5 Here is an excerpt: “Abstract -  Because tissue culture studies have suggested that mesothelial cells might produce large amounts of vimentin, I stained eight mesotheliomas (two fixed in alcohol) for vimentin using the Gown and Vogel monoclonal antibody 43[beta] 8. The two tumors that had alcohol fixed blocks were strongly positive for vimentin, whereas one of the tumors fixed only in formalin showed moderately strong staining and two others showed very weak focal positivity; the remaining tumors were negative. In the mesotheliomas that did stain, both epithelial and spindled elements gave a positive reaction. Three alcohol-fixed lung cancers and two blocks of alcohol-fixed pleura failed to stain for vimentin. By contrast, all mesotheliomas and carcinomas, whether alcohol or formalin fixed, as well as sections of pleura, were strongly positive when stained with anticytokeratin antibody 35[beta] Hl 1. I conclude that the combination of staining for vimentin and keratin might be a useful diagnostic finding in malignant mesothelioma, but that specially fixed material is required for reliable vimentin staining.”

We all owe a debt of gratitude to these fine researchers.  If you found any of these excerpts interesting, please read the studies in their entirety.

Monty Wrobleski is the author of this article. For more information please click on the following links

Depuy Hip Recall

Asbestos Disease

Depuy Hip Recall Attorney

There are no posts related to Mesothelioma and the Potential Accessibility of Tumors.